$STAB #NewsOut March 2, 2022 - Statera Biopharma Submits Phase 1 Clinical Trial Protocol to FDA for Investigational Treatment of Long-Haul COVID-19 https://finance.yahoo.com/news/statera-biopharma-submits-phase-1-123000029.html